EP 39 | PepsiCo Stock Analysis: Will the Cash Recovery Last? copertina

EP 39 | PepsiCo Stock Analysis: Will the Cash Recovery Last?

EP 39 | PepsiCo Stock Analysis: Will the Cash Recovery Last?

Ascolta gratuitamente

Vedi i dettagli del titolo

Offerte di stagione | 0,99 €/mese per i primi 3 mesi

A seguire 9,99 €/mese – si applicano condizioni. Puoi disdire mensilmente.
A proposito di questo titolo
 PepsiCo sold more snacks and generated more operating cash, but its free cash flow still fell slightly short of cash dividends for the first 36 weeks. Can the business keep winning shoppers while protecting margins and funding the payout?Research checked 5 November 2026. PEP.NASDAQ ordinary USD shares, ISIN US7134481081. Recording reference $142.42, the 4 November New York daily close used by the platform. The independent Alpaca IEX daily bar closed at $142.45 on that date, a separate exchange-only print.Public weighted Partial Sell for September 2027 and Buy for September 2031, with separate Watch for Better Entry. Ratings use the platform’s net-yield and reinvestment method.Fixed September 18, 2027 and 2031 targets $141.46 and $191.41. Cumulative price -0.67% and +34.40%. Flat quarterly $1.48, $5.92 annualized, assumes $4.44 and $28.12 future gross cash. September 2026 already paid. Gross cash-plus-price +2.45% and +54.15%, before tax and fees, without reinvestment.PepsiCo AI Consensus · PepsiCo AI Opinions · PepsiCo Profile & Fundamentals · Complete rankings of covered assets and Strongest BuysEarnings and margins. Q3 sales +5.6% reported and +3.1% organic. GAAP EPS +17% and core +2%. Reported margin up, core down. North American savory snack volume improved while net pricing pressured sales.Debt and investment. $51.88bn debt and $11.16bn cash plus short investments. $7.95bn operating cash less $2.18bn capex plus $89m of property sales gives $5.86bn of company free cash flow over 36 weeks. Cash dividends paid were $5.94bn.Cash and restricted cash bridge. $9.20bn plus $7.95bn operations, less $2.35bn investing, $3.90bn financing and $175m FX, ends at $10.73bn within rounding.Cases test repeat purchases and productivity versus discount dependency and tighter margins. Upside tail is unexpected input cost relief. Downside tail is a demand shock from broad food-policy changes. Advisors disagree on cash conversion, demand durability and valuation.All 20 September model steps rise from their original anchor. The initial quarter remains below the November price. July Q2 evidence was available in September, while the October Q3 update came later. Boeing is the separate last-stock comparison. Watch repeat purchases, core margin and normalized cash coverage of dividends.EP 32 | AXA Stock Analysis: Is This Dividend Giant Ready to Soar?. Listen on Substack · Watch on YouTube.EP 35 | Proximus Stock Analysis: Can a Cash Turnaround Send It Soaring?. Listen on Substack · Watch on YouTube.EP 36 | GSK Stock Analysis: Can New Drugs Beat the Patent Cliff?. Listen on Substack · Watch on YouTube.8 October Q3 2026 results · PepsiCo Q3 2026 Form 10-Q · 9 July Q2 prepared management remarks · July board dividend declaration · iPulse AI methodologyFor the bigger picture, visit iPulse AI to explore our complete rankings of covered assets, discover the Strongest Buys, and see the research behind the ratings, all in one place.Primary research conducted through the iPulse AI platform by Future Edge Group.Like, comment and subscribe.We are publishing a new podcast every day of the week except Thursday. Stay tuned for the next podcast on RxSight. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit ipulseai.substack.com
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione